News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ZEN Wei Peu
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,000,000 options to buy
@ $0.5, valued at
$1M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2019 |
3/A
| ZEN Wei Peu (Director) has filed a Form 3/A on Emmaus Life Sciences, Inc. |
| 10/08/2019 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 12,892 shares
@ $3.7, valued at
$47.7k
Bought 20,000 shares
@ $3.9, valued at
$78k
Bought 20,000 shares
@ $4, valued at
$80k
|
|
| 09/03/2019 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 3,400 shares
@ $3.3, valued at
$11.2k
|
|
| 08/29/2019 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,345 shares
@ $2.8, valued at
$6.6k
|
|
| 08/05/2019 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 07/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/12/2019 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on EMMAUS LIFE SCIENCES, INC.|
Txns:
| Bought 303,030 shares
@ $6.6, valued at
$2M
Bought 151,515 shares
@ $6.6, valued at
$1000k
|
|
| 12/21/2018 |
3/A
| ZEN Wei Peu (Director) has filed a Form 3/A on EMMAUS LIFE SCIENCES, INC. |
| 12/20/2018 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on EMMAUS LIFE SCIENCES, INC.|
Txns:
| Bought 100,000 shares
@ $10, valued at
$1M
|
|
| 08/03/2018 |
3
| ZEN Wei Peu (Director) has filed a Form 3 on EMMAUS LIFE SCIENCES, INC. |
|
|